After Hours
$
12.30
Change
+0.46 +3.89%
Volume
Volume 181,073
Aug 11, 2022, 7:40 p.m.
Quotes are delayed by 20 min
Today's close
$ 12.38
$ 11.84
Change
-0.54 -4.36%
Day low
Day high
$11.70
$12.56

52 week low
52 week high
$6.18
$27.96

Market cap
$1.95B
Average volume
5.02M
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-2.40
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on IOVA
-
Biotech Stocks Are Up by Double Digits. It's Still a Bear Market.
- Barron's Online
-
5 Beaten-Up Biotech Stocks Saw Big Share Purchases
- Barron's Online
-
Iovance Biotherapeutics stock price target cut to $20 from $29 at Truist
- Tomi Kilgore
-
Iovance Biotherapeutics stock price target cut to $13 from $26 at Stifel Nicolaus
- Tomi Kilgore
-
Iovance Biotherapeutics upgraded to buy from hold at Stifel Nicolaus
- Tomi Kilgore
-
Iovance Reports Cancer Drug Data That Looks Positive
- Barron's Online
-
Biotech M&A Has Been Slow This Year. Why It Might Get Busier.
- Barron's Online
-
Iovance Stock Falls Almost 40% on Double Dose of Bad News
- Barron's Online
-
Iovance Biotherapeutics stock price target cut to $30 from $55 at Mizuho
- Tomi Kilgore
-
Iovance Biotherapeutics started at buy with $50 stock price target at Truist
- Tomi Kilgore
-
Iovance Biotherapeutics started at buy with $61 stock price target at Mizuho
- Tomi Kilgore
-
The massive decline in the S&P 500 is probably already overdone
- Lawrence G. McMillan
-
Iovance Biotherapeutics started at buy with $27 stock price target at Stifel Nicolaus
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For March 17, 2017
- Benzinga.com
-
- Benzinga.com
-
Chardan Capital Initiates Lion Biotechnologies With Buy
- Benzinga.com
Other News on IOVA
-
Top 5 2nd Quarter Trades of Biondo Investment Advisors, LLC
- GuruFocus.com
-
Iovance Biotherapeutics falls 6% on Q2 2022 bottom line miss
- Seeking Alpha
-
Iovance: TIL Cell Therapy Set To Prove Itself
- Seeking Alpha
-
Bluebird Bio drives gene therapy stocks higher after FDA review
- Seeking Alpha
-
Why Iovance Stock Leaped 17% Higher Today
- Motley Fool
-
Iovance climbs over 15% after multiple insider purchases
- Seeking Alpha
-
Why Iovance Biotherapeutics Was Halved Today
- Motley Fool
-
AVDL, SIGA, PSHG and IOVA among mid-day movers
- Seeking Alpha
-
Iovance sheds half of market cap after melanoma data
- Seeking Alpha
-
Iovance slips after trial data for melanoma candidate
- Seeking Alpha
-
Why Cellectis' Shares Rose 22.7% This Week
- Motley Fool
- Loading more headlines...
Earnings Announcement
Press Releases on IOVA
-
Iovance Biotherapeutics to Present at Upcoming Conferences
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com